5-177091070-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_213647.3(FGFR4):​c.569C>G​(p.Ala190Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000277 in 1,445,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A190T) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000028 ( 0 hom. )

Consequence

FGFR4
NM_213647.3 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.22

Publications

3 publications found
Variant links:
Genes affected
FGFR4 (HGNC:3691): (fibroblast growth factor receptor 4) The protein encoded by this gene is a tyrosine kinase and cell surface receptor for fibroblast growth factors. The encoded protein is involved in the regulation of several pathways, including cell proliferation, cell differentiation, cell migration, lipid metabolism, bile acid biosynthesis, vitamin D metabolism, glucose uptake, and phosphate homeostasis. This protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment, and a cytoplasmic tyrosine kinase domain. The extracellular portion interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3010322).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGFR4NM_213647.3 linkc.569C>G p.Ala190Gly missense_variant Exon 5 of 18 ENST00000292408.9 NP_998812.1 P22455-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGFR4ENST00000292408.9 linkc.569C>G p.Ala190Gly missense_variant Exon 5 of 18 1 NM_213647.3 ENSP00000292408.4 P22455-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000407
AC:
1
AN:
245470
AF XY:
0.00000754
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000277
AC:
4
AN:
1445530
Hom.:
0
Cov.:
33
AF XY:
0.00000419
AC XY:
3
AN XY:
715492
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33160
American (AMR)
AF:
0.00
AC:
0
AN:
44182
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25914
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39098
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85638
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53158
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5724
European-Non Finnish (NFE)
AF:
0.00000182
AC:
2
AN:
1099106
Other (OTH)
AF:
0.0000168
AC:
1
AN:
59550
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 27, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.569C>G (p.A190G) alteration is located in exon 5 (coding exon 4) of the FGFR4 gene. This alteration results from a C to G substitution at nucleotide position 569, causing the alanine (A) at amino acid position 190 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.34
T;T;.;T;.
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.31
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.85
.;T;T;T;T
M_CAP
Benign
0.055
D
MetaRNN
Benign
0.30
T;T;T;T;T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
0.95
L;.;.;L;L
PhyloP100
4.2
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.3
N;N;N;N;N
REVEL
Benign
0.14
Sift
Uncertain
0.0080
D;D;D;D;D
Sift4G
Benign
0.13
T;D;T;T;T
Polyphen
0.011
B;.;.;B;B
Vest4
0.34
MutPred
0.55
Gain of ubiquitination at K186 (P = 0.0632);Gain of ubiquitination at K186 (P = 0.0632);Gain of ubiquitination at K186 (P = 0.0632);Gain of ubiquitination at K186 (P = 0.0632);Gain of ubiquitination at K186 (P = 0.0632);
MVP
0.86
MPC
0.44
ClinPred
0.30
T
GERP RS
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.54
gMVP
0.41
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs751043027; hg19: chr5-176518071; API